Research map: Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy – a post-hoc analysis

Back to the article

Papers in this map

  1. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) · Michael Herdman · 2011 · 10327 citations · Cited by this paper
  2. Burden of illness of Duchenne muscular dystrophy in Belgium: A retrospective, descriptive, cross-sectional study · 2026 · Related
  3. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision · Peter Y. K. Van den Bergh · 2021 · 523 citations · Cited by this paper
  4. Minute-by minute gait variations during the 6-Minute walk test in subjects with myotonic dystrophy type 1 · 2026 · Related
  5. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies · S. I. van Nes · 2011 · 383 citations · Cited by this paper
  6. Congenital myasthenic syndrome due to novel GFPT1 variant presenting with head drop and visual impairment: A case report · 2026 · Related
  7. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies · Ingemar S.J. Merkies · 2002 · 311 citations · Cited by this paper
  8. Not only cross-sectional area: Echogenicity matters in nerve ultrasound studies of patients with motor multifocal neuropathy · 2026 · Related
  9. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial · Ivo N. van Schaik · 2017 · 278 citations · Cited by this paper
  10. Orofacial dysfunction in persons with congenital or childhood-onset neuromuscular disorders · 2026 · Related
  11. Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults · Claus Vinter Bødker Hviid · 2020 · 144 citations · Cited by this paper
  12. Developing endpoints for the cardiac burden in myotonic dystrophy type 1: A workshop report · 2026 · Related
  13. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice · Kenneth C. Gorson · 2010 · 143 citations · Cited by this paper
  14. Expanding repeats, expanding impact: Somatic instability in myotonic dystrophy type 1 · 2026 · Related
  15. Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy · Gwen G. A. van Lieverloo · 2019 · 94 citations · Cited by this paper
  16. Effects of intermittent corticosteroids on scoliosis, bone density, and vertebral fractures in duchenne muscular dystrophy · 2026 · Related
  17. Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy · Lars Høj Markvardsen · 2014 · 64 citations · Cited by this paper
  18. A qualitative study of the discrepancy between patient expectations and assessment practices in 5q-adult spinal muscular atrophy in France · 2026 · Related
  19. Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP · Ivo N. van Schaik · 2019 · 55 citations · Cited by this paper
  20. IMU-based workspace area as a promising complementary tool to assess upper limb function in Neuromuscular diseases: A one-year follow-up · 2026 · Related
  21. Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy · Max E. Adrichem · 2022 · 35 citations · Cited by this paper
  22. Outcome in chronic inflammatory demyelinating polyneuropathy: A systematic review and meta‐analysis · Ali Al‐Zuhairy · 2023 · 20 citations · Cited by this paper
  23. Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy · Marco Luigetti · 2024 · 19 citations · Cited by this paper
  24. Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity · Frauke Stascheit · 2021 · 16 citations · Cited by this paper
  25. Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review · Louise Sloth Kodal · 2023 · 16 citations · Cited by this paper
  26. Usefulness of serum neurofilament light chain in chronic inflammatory demyelinating polyradiculoneuropathy · Arnau Llauradó · 2025 · 13 citations · Cited by this paper
  27. Standardized Tapering off Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy · Lars Høj Markvardsen · 2023 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)